Skip to content

Clinical trials

Gout trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gout Country / region: China Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20111
20121
20151
20161
20172
20181
20194
20201
20216
20221
20234
20244
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Unknown status8
Recruiting5
Active, not recruiting2
Not yet recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Jiangsu HengRui Medicine Co., Ltd.6
Shenyang Sunshine Pharmaceutical Co., LTD.3
Novartis Pharmaceuticals2
Peking University Third Hospital2
The Affiliated Hospital of Qingdao University2
Atom Therapeutics Co., Ltd1
Changchun GeneScience Pharmaceutical Co., Ltd.1
Eisai Co., Ltd.1
Guang'anmen Hospital of China Academy of Chinese Medical Sciences1
Guangzhou Ruianbo Pharmaceutical Technology Co., Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gout33
Hyperuricemia12
Arthritis, Gouty1
Arthritis, Rheumatoid1
Coronary Artery Disease1
Metabolic Diseases1
Nephrolithiasis1
Obesity1
Rheumatic Diseases1
Synovitis, Pigmented Villonodular1

Trials

Showing 51 to 33 of 33. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.